Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Summary

Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and effects on low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) of single-dose ARO-DIMERPA and multiple doses of ARO-DIMERPA in adult participants with mixed hyperlipidemia.

Timeline

Start

2025-12-22

Primary completion

2026-09-30

Completion

2027-07

Drugs

Indications